How have ATOS and NSPR total returns compared?

Over the past 10 years, ATOS delivered -39.47% and NSPR delivered -68.24% annualized total return. Past performance doesn't predict future results.

Atossa Therapeutics, Inc. (ATOS) vs InspireMD, Inc. (NSPR)

A side-by-side comparison of Atossa Therapeutics, Inc. and InspireMD, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

ATOS

Atossa Therapeutics, Inc.

$25M

$2.48HealthcareDelayed quote: Oct 6, 2026, 12:16 PM EDT

NSPR

InspireMD, Inc.

$26M

$0.56HealthcareDelayed quote: Oct 6, 2026, 12:23 PM EDT

Total return — ATOS vs NSPR

growth of $100 · dividends reinvested · last 10y

ATOS -99.4% (-39.6%/yr)NSPR -100.0% (-68.2%/yr)ATOS compounded faster over this window

Log scale — wide-divergence pair

ATOS NSPR

ATOS vs NSPR: by the numbers

•NSPR is the larger company ($26M vs $25M market cap).
•Both run net losses; ATOS's is the smaller (0.00% vs -355.17% net margin).

Metrics side by side

Valuation

Metric	ATOS	NSPR
P/S ratio	N/A	2.42
P/B ratio	0.92	0.83

Profitability

Metric	ATOS	NSPR
Gross margin	0.00%	29.50%
Operating margin	0.00%	-546.97%
Net margin	0.00%	-355.17%
ROE	-140.55%	-122.19%
ROIC	-146.30%	-153.04%

Growth (annualized)

Metric	ATOS	NSPR
Revenue CAGR (5Y)	N/A	27.79%
Total return CAGR (5Y)	-44.50%	-36.91%

Frequently asked

How have ATOS and NSPR total returns compared?: Over the past 10 years, ATOS delivered -39.47% and NSPR delivered -68.24% annualized total return. Past performance doesn't predict future results.

Go deeper

Full ATOS analysis Full NSPR analysis Interactive comparison tool

Dig into the metrics

Atossa Therapeutics ROE InspireMD ROE Atossa Therapeutics operating margin InspireMD operating margin Atossa Therapeutics revenue growth InspireMD revenue growth Atossa Therapeutics free cash flow InspireMD free cash flow

Atossa Therapeutics & InspireMD appear in these rankings

Fastest Revenue Growth Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.